Related Experiment Video
Updated: Jun 24, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation
Atsushi Hosui1, Akiko Kimura, Daisuke Yamaji
1Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. hosui@gh.med.osaka-u.ac.jp
Abstract:
The molecular mechanisms underlying the development of hepatocellular carcinoma are not fully understood. Liver-specific signal transducer and activator of transcription (STAT) 5A/B-null mice (STAT5-LKO) were treated with carbon tetrachloride (CCl(4)), and histological analyses revealed liver fibrosis and tumors. Transforming growth factor (TGF)-beta levels and STAT3 activity were elevated in liver tissue from STAT5-LKO mice upon CCl(4) treatment. To define the molecular link between STAT5 silencing and TGF-beta up-regulation, as well as STAT3 activation, we examined STAT5-null mouse embryonic fibroblasts and primary hepatocytes. These cells displayed elevated TGF-beta protein levels, whereas messenger RNA levels remained almost unchanged. Protease inhibitor studies revealed that STAT5 deficiency enhanced the stability of mature TGF-beta. Immunoprecipitation and immunohistochemistry analyses demonstrated that STAT5, through its N-terminal sequences, could bind to TGF-beta and that retroviral-mediated overexpression of STAT5 decreased TGF-beta levels. To confirm the in vivo significance of the N-terminal domain of STAT5, we treated mice that expressed STAT5 lacking the N terminus (STAT5-DeltaN) with CCl(4). STAT5-DeltaN mice developed CCl(4)-induced liver fibrosis but no tumors. In conclusion, loss of STAT5 results in elevated TGF-beta levels and enhanced growth hormone-induced STAT3 activity. We propose that a deregulated STAT5-TGF-beta-STAT3 network contributes to the development of chronic liver disease.
Insights
Loss of signal transducer and activator of transcription (STAT) 5 in mice leads to increased transforming growth factor-beta (TGF-beta) and STAT3 activity, promoting liver fibrosis and cancer. Restoring STAT5 function prevents tumor development.
Area of Science:
- Hepatology
- Molecular Biology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) development mechanisms are unclear.
- Signal transducer and activator of transcription (STAT) 5 plays a role in liver health.
- STAT5 deficiency is linked to liver disease progression.
Purpose of the Study:
- To elucidate the molecular link between STAT5, transforming growth factor-beta (TGF-beta), and STAT3 in liver disease.
- To investigate the role of STAT5 in regulating TGF-beta stability and activity.
- To determine the in vivo significance of STAT5 in carbon tetrachloride (CCl4)-induced liver injury and tumorigenesis.
Main Methods:
- Utilized liver-specific STAT5A/B-null (STAT5-LKO) and STAT5 N-terminus deleted (STAT5-DeltaN) mouse models.
- Administered carbon tetrachloride (CCl4) to induce liver fibrosis and tumors.
- Performed histological analyses, Western blotting, immunoprecipitation, and immunohistochemistry.
Main Results:
- STAT5-LKO mice exhibited liver fibrosis, elevated TGF-beta protein levels, and increased STAT3 activity upon CCl4 treatment.
- STAT5 deficiency enhanced mature TGF-beta protein stability without altering mRNA levels.
- STAT5 directly binds to TGF-beta via its N-terminal domain, and its absence promotes CCl4-induced liver fibrosis but not tumors in STAT5-DeltaN mice.
Conclusions:
- Loss of STAT5 leads to elevated TGF-beta levels and enhanced STAT3 activity.
- A deregulated STAT5-TGF-beta-STAT3 signaling network contributes to chronic liver disease and hepatocellular carcinoma development.
- STAT5's N-terminal domain is crucial for preventing CCl4-induced liver tumorigenesis.
Related Concept Videos
Cirrhosis II: Pathophysiology
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
